CIK 0001787400 · Non-accelerated filer<br>Smaller reporting company
Nkarta, Inc.
Sign in to watch- Ticker
- NKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474515206
- Phone
- (925) 407-1049
- Business address
- 1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-20 | Mahmood Nadir See Remarks | Sale | −526 | $4.85 | $3K | 85,776 |
| 2023-06-20 | HASTINGS PAUL J Chief Executive Officer | Sale | −1,704 | $4.85 | $8K | 313,402 |
| 2023-06-07 | George Simeon Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2023-06-07 | Behbahani Ali Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2023-06-07 | Thedinga Angela Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2023-06-07 | PATTERSON LEONE D Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2023-06-07 | Dybbs Michael Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2023-06-07 | Azzam Fouad Oscar Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2023-06-07 | Scheiner Zachary Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2023-06-07 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 | ||
| 2023-01-17 | Trager James Chief Scientific Officer | Sale | −1,115 | $5.49 | $6K | 98,557 |
| 2023-01-17 | Shook David Chief Medical Officer | Sale | −175 | $5.49 | $961 | 60,302 |
| 2023-01-17 | Mahmood Nadir See Remarks | Sale | −1,122 | $5.49 | $6K | 84,302 |
| 2023-01-17 | HASTINGS PAUL J Chief Executive Officer | Sale | −3,691 | $5.49 | $20K | 313,106 |
| 2023-01-17 | Hager Alicia J. Chief Legal Officer | Sale | −1,103 | $5.49 | $6K | 57,197 |
| 2023-01-17 | Brandenberger Ralph Chief Technical Officer | Sale | −491 | $5.49 | $3K | 28,309 |
| 2023-01-13 | Trager James Chief Scientific Officer | Grant or award | +37,500 | 99,672 | ||
| 2023-01-13 | Trager James Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2023-01-13 | Shook David Chief Medical Officer | Grant or award | +37,500 | 60,477 | ||
| 2023-01-13 | Shook David Chief Medical Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 |
Page 6 of 8 · 159 trades